Immusoft

Discovery Genomics, Inc. is an early-stage functional genomics company focused on discovering gene functions, validating drug targets, and designing therapeutic agents based on genomic information. The company holds exclusive licenses from the University of Minnesota for technologies related to "knock-downs" in Zebrafish, utilizing its proprietary Morphant technology, as well as the Sleeping Beauty Transposon. These technologies are instrumental in functional genomics and drug target discovery, with potential applications in gene therapy. The Morphant "knock-downs" enable the suppression and study of specific gene functions, while the Zebrafish model system offers a faster and more cost-effective method for gene discovery compared to other vertebrate models. As of March 2016, Discovery Genomics operates as a subsidiary of Immusoft Corporation.